Navigation path


Environmental risk assessment of pharmaceuticals
EC contribution
: € 2.797.198
: 36 months
Starting date
: 01/10/2004
Funding scheme
: Specific Targeted Research Project
: human and veterinary pharmaceuticals, antibiotics
Contract/Grant agreement number
: SSPI-CT-2003-511135
Project web-site


ERAPharm aimed to improve existing knowledge and methods for evaluating potential risks posed by human and veterinary pharmaceuticals to the environment. The consortium addressed the different aspects of environmental risk assessment (ERA) of pharmaceuticals, including exposure modelling as well as effects on microorganisms, aquatic and terrestrial invertebrates and fish. Based on the results of the fate and effect studies, recommendations have been provided on how to improve current European ERA procedures for human and veterinary pharmaceuticals.

ERAPharm has been grouped into eight interdependent Work Packages

[+] Read More